A Distinguished Corporate Law Practice
Our deep experience in Europe and the US means we are regularly entrusted to handle the highest regulated, sensitive, complex, and sophisticated transactions in Malta and around the world, particularly in the healthcare, life sciences, pharmaceutical, and medical device industries. AnthiaZammit Legal has contributed to transformative multinational transactions in corporate law in order to advance our clients’ interests.
The firm provide sound legal and commercial advice on the highly bespoke processes and contracts that are the hallmark of private Mergers & Acquisitions. Meticulous attention to detail and intense focus on significant commercial points can make a meaningful difference for our clients. We strive to make that difference in every transaction we work on.
We counsel both public and private acquirors and targets, advising on a wide range of corporate law matters, including:
- Multijurisdictional transactions
- Regulatory compliance
- Regulatory advisory
- Regulatory submissions and filings
- Assessing regulatory and legislative developments
- Managing important public relations
- Cross-Border and International Mergers and Acquisitions
- Restructurings
- Financings
- Joint Ventures
- Internal Investigation
- Private Equity
- Strategic Investments
- Spin-offs and Split-ups
- Capital-Raising Transactions
- Takeover Defense
- Buyouts
- Shareholder Activism
- Shareholders rights plans
- Shareholders agreements
- Share option agreements
- Executive and management succession and transition
- Board composition
- Board diversity
- Executive compensation and benefits
- Assisting with management changes
- Crisis management
- Risk management
- Internal investigations
- Contract negotiation and drafting
- Strategic transactions
- Due diligence
- Company searches
- Company formation in Malta
- Corporate Governance
Corporate Governance
Corporate governance represents an increasingly complex and critical area of focus for companies. As boards of directors and management teams consider governance policies, they must also ensure that they protect long-term shareholder value, balance stakeholders interests, directors’ independence, and retain the flexibility to deal with takeover attempts and activist campaigns.
We are thought leaders in the area of corporate governance. We have represented major global corporations in connection with corporate governance and related matters; we have also advised special committees of boards of directors, including the boards of multinational pharmaceutical companies, in connection with corporate governance investigations and related matters.
Our engagements range from prospective counseling on risk management and compliance matters, to guiding companies on fact‑finding with respect to potential violations of laws or regulations, or shareholder demands, and to managing the client’s responses to investigations and enforcement actions by governmental and regulatory authorities.
Comments are closed.